Suchen Sie nach Informationen zu Galderma-Unternehmenszentrale? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.
https://www.galderma.com/
Advancing dermatology for every skin story. Everyone's skin is unique and we each have our own skin story. At Galderma, we embrace these differences and offer cutting-edge, premium brands that fit people's individual needs, across the full spectrum of dermatology through Aesthetics, Consumer Care and Prescription Medicine. LEARN MORE.
https://www.galderma.com/careers
At Galderma, we expect our employees to uphold four key commitments as we strive to become the leading dermatology company in the world. These commitments are at the heart of the behavior that impacts how we serve our consumers, patients and healthcare professionals: • We listen to consumers, patients and customers, always putting their needs ...
https://www.galdermahcp.com/
Dermatologist, Principal Investigator, certified specialist in internal medicine & dermatology (Canada, U.S.) WARREN J. WINKELMAN, MD PhD FAAD. Head of Global Medical Affairs Strategy, Prescription Medicines for Galderma. DHAVAL G. BHANUSALI, MD, FAAD*. Board Certified Dermatologist & Founder of Hudson Dermatology and Laser Surgery, NYC.
https://en.wikipedia.org/wiki/Galderma
https://suppliers.galderma.com/
Welcome to the Galderma Supplier Page – Our dedicated resource for Suppliers . Galderma’s suppliers are invited to use our Source-to-Pay platform, ONEBUY, to streamline all transactions. This platform includes the Coupa Supplier Portal (CSP) tool and is intended to be the single point of contact between Galderma and our suppliers.
https://www.galdermahcp.com/aesthetics
Our Products. At Galderma, innovation is a cornerstone of our commitment to advancing dermatology. Galderma stands out as one of the few forces capable of inventing, developing and bringing to market truly innovative dermatological solutions.
https://www.reuters.com/markets/europe/eqt-pushes-back-galderma-ipo-plans-amid-market-turmoil-sources-2022-05-13/
EQT's Galderma on Wednesday said its injectable drug nemolizumab helped patients suffering from the rare skin disease prurigo nodularis in a trial, potentially underpinning the owner's ambitions ...
Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Galderma-Unternehmenszentrale gefunden haben.
